Join NCCOR on August 28, 2025, from 3–4 p.m. ET for the next Connect & Explore webinar titled “Nutritional Implications of GLP-1 Medications in Obesity Care.” The use of obesity medications (OM), particularly GLP-1 agonists, has surged in recent years as evidence shows their effectiveness in facilitating weight reduction and improvements in cardiometabolic and health outcomes and quality of life. However, while these medications can result in reduced appetite and hunger, emerging research suggests they may also increase the risk of nutritional deficiencies and adverse changes in body composition, especially if dietary guidance is insufficient. Despite growing use, there is limited understanding of the nutritional implications of GLP-1 OM and how to best assess and mitigate related risks.
During this 1-hour webinar, experts will highlight the nutritional risks associated with the use of GLP-1 OM and discuss nutrition-related indicators that should be monitored for patients using GLP-1 OM. Presentations will explore the impact of these medications on diet, whether GLP-1 OM use results in nutrient deficiencies, and related clinical indicators that can define nutritional deficiency risk prior to the start of GLP-1 OM. This webinar will feature:
- Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP, Integrative Medical Weight Management
- Jaime P. Almandoz, MD, MBA, FTOS, University of Texas Southwestern Medical Center
Registration for the webinar is free, but space is limited, so register early to secure a spot. Please consider sharing this information on your social networks using the hashtag #ConnectExplore. We will live-tweet the webinar, so follow the conversation at @NCCOR. The webinar will be recorded and archived on www.nccor.org for those unable to attend.